Acquired crizotinib-resistant pulmonary adenocarcinoma and subsequent primary gallbladder cancer: A case report

Proto-oncogene-oriented targeted therapy has limited benefits in elderly patients with multiple primary tumors. PATIENT CONCERNS: A woman with anaplastic lymphoma kinase-positive lung adenocarcinoma developed acquired resistance after 3 years of targeted therapy with crizotinib. DIAGNOSES: Diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Min, Chen, Ruilin, Zheng, Suqun, Wang, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019204/
https://www.ncbi.nlm.nih.gov/pubmed/36930086
http://dx.doi.org/10.1097/MD.0000000000033162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019204/
https://www.ncbi.nlm.nih.gov/pubmed/36930086
http://dx.doi.org/10.1097/MD.0000000000033162

Ejemplares similares